Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,516
Closed -$153K 4224
2023
Q2
$153K Sell
25,516
-3,211
-11% -$25.7K ﹤0.01% 3791
2023
Q1
$214K Buy
28,727
+22,064
+331% +$221K ﹤0.01% 3880
2022
Q4
$82.6K Buy
+6,663
New +$117K ﹤0.01% 4393
2021
Q4
Sell
-6,020
Closed -$372K 5351
2021
Q3
$372K Buy
6,020
+555
+10% +$36.5K ﹤0.01% 4244
2021
Q2
$464K Sell
5,465
-59,926
-92% -$5.47M ﹤0.01% 4069
2021
Q1
$5.17M Buy
65,391
+18,396
+39% +$1.19M 0.01% 1818
2020
Q4
$2.74M Buy
46,995
+11,518
+32% +$542K ﹤0.01% 2342
2020
Q3
$1.2M Buy
35,477
+4,326
+14% +$164K ﹤0.01% 2746
2020
Q2
$1.44M Buy
31,151
+17,866
+134% +$497K ﹤0.01% 2666
2020
Q1
$210K Sell
13,285
-1,015
-7% -$24.2K ﹤0.01% 3626
2019
Q4
$392K Buy
14,300
+792
+6% +$21.2K ﹤0.01% 3515
2019
Q3
$397K Buy
13,508
+9,777
+262% +$291K ﹤0.01% 3319
2019
Q2
$107K Buy
3,731
+2,456
+193% +$82.7K ﹤0.01% 3541
2019
Q1
$54K Buy
1,275
+106
+9% +$3.81K ﹤0.01% 3510
2018
Q4
$36K Buy
+1,169
New +$43.5K ﹤0.01% 3692
2016
Q4
Sell
-1,099
Closed -$31K 3411
2016
Q3
$31K Buy
+1,099
New +$30.8K ﹤0.01% 3331
2016
Q1
Sell
-5,926
Closed -$422K 3378
2015
Q4
$422K Buy
+5,926
New +$402K ﹤0.01% 3177

Other funds holding AFMD

D.E. Shaw & Co's AFMD Position: Q3 2023 in Review

D.E. Shaw & Co sold out of Affimed (AFMD) in Q3 2023, closing a stake of 25,516 shares — an estimated $153K sold.

D.E. Shaw & Co first reported a position in AFMD in Q4 2015 and held it in 17 quarters. The position peaked at $5.17M in Q1 2021. 61 funds tracked by Wall St. Rank hold AFMD as of Q3 2023.

  • D.E. Shaw & Co reported no remaining Affimed position as of Q3 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 25,516 Affimed shares in Q3 2023, an estimated $153K.
  • D.E. Shaw & Co first reported a position in Affimed in Q4 2015 and held it in 17 quarters.
  • D.E. Shaw & Co's Affimed position peaked at $5.17M in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Affimed as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.